Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT ... Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants that are drivers of cancer and proliferative disorders. Its other drug candidate is BLU 554 FOR Advanced Hepatocellular Carcinoma, and BLU-667 for Ret Mutations, Fusions, and Predicted Resistant Mutants. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.22 | -1.93464052288 | 114.75 | 118.25 | 112.39 | 778331 | 114.25871092 | CS |
4 | 25.49 | 29.2853860294 | 87.04 | 118.25 | 86.72 | 944404 | 103.76802844 | CS |
12 | 11.03 | 10.8669950739 | 101.5 | 118.25 | 85.91 | 707041 | 97.66918437 | CS |
26 | 4.72 | 4.37807253502 | 107.81 | 118.25 | 80.675 | 696048 | 94.12829159 | CS |
52 | 29.25 | 35.1224783862 | 83.28 | 121.9 | 72.24 | 701510 | 95.48356492 | CS |
156 | 41.34 | 58.0699536452 | 71.19 | 121.9 | 37.82 | 703844 | 70.70778823 | CS |
260 | 48.38 | 75.4169914263 | 64.15 | 125.61 | 37.82 | 626529 | 75.25326206 | CS |
Symbole | Prix | Vol. |
---|---|---|
TCTMTCTM Kids IT Education Inc | US$ 0,764 (321,87%) | 729,71M |
NVDANVIDIA Corporation | US$ 120,07 (-3,67%) | 388,53M |
RIMEAlgorhythm Holdings Inc | US$ 0,02565 (5,12%) | 338,7M |
BHATBlue Hat Interactive Entertainment Technology | US$ 0,0355 (-11,25%) | 236,05M |
CLEUChina Liberal Education Holdings Ltd | US$ 0,1938 (30,77%) | 234,74M |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales